Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer.

Autor: Ionkina AA; Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, 92697, USA., Balderrama-Gutierrez G; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA, 92697, USA., Ibanez KJ; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA, 92697, USA., Phan SHD; Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, 92697, USA., Cortez AN; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA, 92697, USA., Mortazavi A; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA, 92697, USA. ali.mortazavi@uci.edu.; Center for Complex Biological Systems, University of California Irvine, Irvine, CA, 92697, USA. ali.mortazavi@uci.edu., Prescher JA; Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA, 92697, USA. jpresche@uci.edu.; Department of Chemistry, University of California Irvine, Irvine, CA, 92697, USA. jpresche@uci.edu.; Department of Pharmaceutical Sciences, University of California Irvine, Irvine, CA, 92697, USA. jpresche@uci.edu.
Jazyk: angličtina
Zdroj: Breast cancer research : BCR [Breast Cancer Res] 2021 Sep 27; Vol. 23 (1), pp. 93. Date of Electronic Publication: 2021 Sep 27.
DOI: 10.1186/s13058-021-01468-x
Abstrakt: Background: Cancer metastasis is a complex process involving the spread of malignant cells from a primary tumor to distal organs. Understanding this cascade at a mechanistic level could provide critical new insights into the disease and potentially reveal new avenues for treatment. Transcriptome profiling of spontaneous cancer models is an attractive method to examine the dynamic changes accompanying tumor cell spread. However, such studies are complicated by the underlying heterogeneity of the cell types involved. The purpose of this study was to examine the transcriptomes of metastatic breast cancer cells using the well-established MMTV-PyMT mouse model.
Methods: Organ-derived metastatic cell lines were harvested from 10 female MMTV-PyMT mice. Cancer cells were isolated and sorted based on the expression of CD44 low /EpCAM high or CD44 high /EpCAM high surface markers. RNA from each cell line was extracted and sequenced using the NextSeq 500 Illumina platform. Tissue-specific genes were compared across the different metastatic and primary tumor samples. Reads were mapped to the mouse genome using STAR, and gene expression was quantified using RSEM. Single-cell RNA-seq (scRNA-seq) was performed on select samples using the ddSeq platform by BioRad and analyzed using Seurat v3.2.3. Monocle2 was used to infer pseudo-time progression.
Results: Comparison of RNA sequencing data across all cell populations produced distinct gene clusters. Differential gene expression patterns related to CD44 expression, organ tropism, and immunomodulatory signatures were observed. scRNA-seq identified expression profiles based on tissue-dependent niches and clonal heterogeneity. These cohorts of data were narrowed down to identify subsets of genes with high expression and known metastatic propensity. Dot plot analyses further revealed clusters expressing cancer stem cell and cancer dormancy markers. Changes in relevant genes were investigated across pseudo-time and tissue origin using Monocle2. These data revealed transcriptomes that may contribute to sub-clonal evolution and treatment evasion during cancer progression.
Conclusions: We performed a comprehensive transcriptome analysis of tumor heterogeneity and organ tropism during breast cancer metastasis. These data add to our understanding of metastatic progression and highlight targets for breast cancer treatment. These markers could also be used to image the impact of tumor heterogeneity on metastases.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: